胰腺癌治療和診斷市場，按類型（治療和診斷），按地區 - 規模、份額、前景和機會分析，2022-2028

胰腺癌是在胰腺細胞中形成的癌症。 當胰腺細胞由於胰腺細胞的變化（突變）而失去控制時，就會發生胰腺癌。 這種癌症可以藉助超聲波、計算機斷層掃描 (CT) 掃描、磁共振成像 (MRI) 和正電子發射斷層掃描 (PET) 掃描來診斷。 治療包括手術、放射療法、化學療法或這些療法的組合。

市場動態

胰腺癌發病率和患病率的上升、新治療藥物的不斷開發、人口老齡化的加劇、對安全有效治療藥物的需求不斷增加以及公眾對胰腺癌的認識不斷提高是預計增加胰腺癌發病率的主要因素胰腺癌治療和診斷市場的增長。

例如，2021 年 1 月，Myriad Genetics Inc. 和 Illumina Inc. 聯合開發了基於試劑盒的 myChoice 伴隨診斷測試版本，可用於檢測國際市場的胰腺癌。

此外，2020 年 9 月，印度醫學研究理事會 (ICMR) - 國家癌症預防與研究所 (NICPR) 發起了一項倡議，旨在提高人們對包括胰腺癌在內的癌症的認識，主題是“印度抗癌” 。”推出 www.cancerindia.org，這是一個門戶網站，提供有關印度主要癌症的信息，重點放在預防和治療上。

這項研究的主要特點

• 本報告對全球胰腺癌治療和診斷市場進行了深入分析，顯示了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR%)。 ) 提供。
• 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，對全球胰腺癌治療和診斷市場的主要參與者進行了概況分析。
• 參與這項研究的主要公司包括 F.Hoffmann-La Roche AG、Merck KgaA、Apexigen Inc.、Immunovia AB、Viatris Inc.、Amgen Inc.、AstraZeneca PLC、Bristol-Myers Squibb、Novartis AG、Pfizer Inc.、Myriad Genetics Inc.、Canon Medical Systems Corporation、FUJIFILM Holdings Corporation、波士頓科學公司和 Rafael Holdings Inc.（Rafael Pharmaceuticals）等。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 本研究報告面向全球胰腺癌治療和診斷市場的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球胰腺癌治療和診斷市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按類型分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 胰腺癌的發病率和患病率上升
  • 與診斷和治療相關的高昂費用
  • 對安全有效的治療藥物的需求不斷增加
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/批准
• 害蟲分析
• 對 PORTER 的分析
• 合併/收購場景

第 4 章全球胰腺癌治療劑/診斷劑市場 - 冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 的流行病學特徵
• 供應方和需求方分析
• 經濟影響

第 5 章全球胰腺癌治療和診斷市場：按類型，2017-2028

• 治療藥物
• 診斷

第 6 章。全球胰腺癌治療和診斷市場：按地區劃分，2017-2028

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地區

第七章競爭格局

• F Hoffmann-La Roche AG
• Merck KgaA
• Apexigen Inc.
• Immunovia AB
• Viatris Inc.
• Amgen Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb
• Novartis AG
• Pfizer Inc.
• Myriad Genetics Inc.
  • Canon Medical Systems Corporation
• FUJIFILM Holdings Corporation
• Boston Scientific Corporation
• Rafael Holdings Inc.（Rafael Pharmaceuticals）

第 8 章

• 調查方法介紹
• 關於出版商

Pancreatic cancer is cancer that forms in the cells of the pancreas. Pancreatic cancer occurs when changes (mutations) in the pancreas cells lead them to multiply out of control. The cancer can be diagnosed with the help of ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Treatment may include surgery, radiation, chemotherapy, or a combination of these.

Market Dynamics:

Rise in incidence and prevalence of pancreatic cancer, rise in development of novel therapeutics, growing geriatric population, increase in demand for safe and effective therapeutics, and increase in awareness among people are major factors expected to augment growth of the global pancreatic cancer therapeutics and diagnostic market.

For instance, in January 2021, Myriad Genetics Inc. and Illumina Inc. collaborated to develop a kit-based version of the myChoice companion diagnostic test for international markets, which can be used to detect pancreatic cancer.

Moreover, in September 2020, the Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR) launched www.cancerindia.org with the theme 'India against Cancer, a portal that provides information on the leading cancers in India with the major focus on awareness, prevention, and treatment of cancers, including pancreatic cancer.

Key features of the study:

• This report provides in-depth analysis of the global pancreatic cancer therapeutics and diagnostic market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global pancreatic cancer therapeutics and diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include F.Hoffmann-La Roche AG, Merck KgaA, Apexigen Inc., Immunovia AB, Viatris Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb, Novartis AG, Pfizer Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, and Rafael Holdings Inc. (Rafael Pharmaceuticals), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global pancreatic cancer therapeutics and diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pancreatic cancer therapeutics and diagnostic market.

Detailed Segmentation:

• Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type:
  • Treatment
  • Diagnostics
• Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • F.Hoffmann-La Roche AG
  • Merck KgaA
  • Apexigen Inc.
  • Immunovia AB
  • Viatris Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb
  • Novartis AG
  • Pfizer Inc.
  • Myriad Genetics Inc.
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Boston Scientific Corporation
  • Rafael Holdings Inc. (Rafael Pharmaceuticals)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in incidence and prevalence of pancreatic cancer
  • High cost associated with diagnosis and treatments
  • Increase in demand for safe and effective therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Pancreatic Cancer Therapeutics and Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

7. Competitive Landscape

• F Hoffmann-La Roche AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Apexigen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Immunovia AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Viatris Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol-Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Myriad Genetics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
• Strategies
  • Canon Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• FUJIFILM Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Rafael Holdings Inc. (Rafael Pharmaceuticals)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

8. Section

• Research Methodology
• About us